Transforming Drug Discovery Through Foundation Models & Generative AI

​Generative AI Drug Discovery & Development Summit at JPM 2026

​This event brings together leading pharma CEOs, heads of R&D, top academic researchers and life science investors for a productive fireside panel and session to explore the next generation of discovery tools focusing on AI-driven protein de novo design and AI foundation model.

​Discover how cutting-edge AI systems can revolutionize drug discovery by shortening development cycles, enhancing decision-making, and scaling across programs.

​Agenda:

• ​4:30 - 5 pm: Registration

• ​5 - 5:10 pm: Opening Remark

  • ​Wei Liu, CEO of BioMap

• ​5:10 - 5:25 pm: AI Development Trends, Opportunities in Drug Development and Healthcare

  • ​TBD

• ​5:25 - 5:40 pm: De Novo Protein Design

  • ​Dr. Per Greisen, Head of Protein Design, BioMap

• ​5:40 - 6:15 pm: Panel Discussion:

  • ​MNCs and Investors on AI in Drug Discovery: Opportunities and Challenges

    • ​OrbiMed, Sanofi, Thermo Fisher, TBD

• ​6:15 - 6:30 pm: Break & Dinner

• ​6:30 - 6:45 pm: AI Closed-Loop R&D System

• ​6:45 - 7:15 pm: Collaboration Ceremony

• ​7:15 - 7:45 pm: Panel Discussion

  • ​Partner Insights and Shared Vision on Leveraging AI to Improve R&D Discovery Efficiency

• ​7:45 - 9:30 pm: Networking Event

​This is a unique opportunity to connect with forward-thinking executives dedicated to pioneering innovation in biotech and pharma.

​Please note, this event is exclusively for executive leaders—not for representatives of service providers or similar organizations.